115 related articles for article (PubMed ID: 34040294)
1. Rare thyroid Cartilage Metastases Detected on
Gupta N; Verma R; Belho ES
Indian J Nucl Med; 2021; 36(1):39-42. PubMed ID: 34040294
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Cartilage Metastases on F-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: A Tale of Two Cases with a Brief Review of Literature.
Tripathy S; Parida GK; Singhal A; Shamim SA; Kumar R
Indian J Nucl Med; 2019; 34(3):220-222. PubMed ID: 31293303
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of Thyroid Cartilage Metastases Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Verma S; Singh MM; Deswal S; Kakkar L
Indian J Nucl Med; 2023; 38(2):172-173. PubMed ID: 37456176
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Thyroid Cartilage Lesion from Prostatic Adenocarcinoma on
Gupta N; Verma R; Belho ES
Indian J Nucl Med; 2021; 36(2):183-188. PubMed ID: 34385791
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Follicular thyroid carcinoma metastasizing to rare sites and exhibiting variable inter-lesional heterogeneity on
Parghane RV; Basu S
World J Nucl Med; 2021; 20(3):312-315. PubMed ID: 34703402
[TBL] [Abstract][Full Text] [Related]
7. Herniated Urinary Bladder Detected on
Gupta N; Verma R; Belho ES
Indian J Nucl Med; 2020; 35(2):172-173. PubMed ID: 32351277
[TBL] [Abstract][Full Text] [Related]
8. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Metastasis from Visceral Organs:
Gupta N; Malik D; Verma R; Belho ES; Manocha A
Indian J Nucl Med; 2019; 34(3):205-208. PubMed ID: 31293299
[TBL] [Abstract][Full Text] [Related]
10. Rare Thyroid Cartilage and Diaphragm Metastases from Lung Cancer Visualized on F-18 FDG-PET/CT Imaging.
Ozcan Kara P; Kara Gedik G; Sarı O; Ozbek O
Mol Imaging Radionucl Ther; 2011 Aug; 20(2):70-2. PubMed ID: 23486533
[TBL] [Abstract][Full Text] [Related]
11. Presentation of Unusual Tracheal Metastasis on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography after 9 Years in Postnephrectomy Patient of Renal Cell Carcinoma: A Case Report and Review of Literature.
Parghane RV; Sood A; Vaiphei K; Aggarwal AN; Mittal BR
World J Nucl Med; 2017; 16(3):240-242. PubMed ID: 28670185
[TBL] [Abstract][Full Text] [Related]
12. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
14. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
[TBL] [Abstract][Full Text] [Related]
15. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
16. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
17. Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.
Kim MH; O JH; Ko SH; Bae JS; Lim DJ; Kim SH; Baek KH; Lee JM; Kang MI; Cha BY; Lee KW
Thyroid; 2012 Feb; 22(2):157-64. PubMed ID: 22224820
[TBL] [Abstract][Full Text] [Related]
18. Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
Öztürk H
Cancer Res Treat; 2015 Oct; 47(4):834-43. PubMed ID: 25687863
[TBL] [Abstract][Full Text] [Related]
19. Rare Presentation of Metastatic Endometrioid Adenocarcinoma of Uterus Mimicking as Second Primary in Urinary Bladder on
Sharma A; Vadi SK; Sood A; Mete UK; Kakkar N; Vashishta RK; Mittal BR
Indian J Nucl Med; 2019; 34(2):169-170. PubMed ID: 31040537
[TBL] [Abstract][Full Text] [Related]
20. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.
Dennis K; Hay JH; Wilson DC
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
